相关实验视频
Updated: Aug 7, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
概括
贝克洛梅他二酸喷雾剂有助于减少慢性支气管喘患者口服皮质类固醇的使用. 这导致上腺功能改善和较少的类固醇副作用,具有良好的耐受性.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性支气管喘往往需要长期的口服皮质类固醇治疗.
- 口服皮质类固醇与显著的全身副作用和上腺抑制有关.
- 需要使用替代治疗策略来治疗喘并减少对皮质类固醇的依赖.
研究的目的:
- 评估贝克洛梅他二酸喷雾剂在慢性支气管喘患者减少口服皮质类固醇需求方面的疗效.
- 评估贝克洛梅他气溶治疗对上腺功能和类固醇相关毒性反应的影响.
主要方法:
- 一个随机的,安慰剂控制的试验,涉及30名患有慢性支气管喘需要口服皮质类固醇治疗的患者.
- 患者在12周内接受了贝克洛美沙二 propionate 喷雾剂或无效喷雾剂安慰剂.
- 在接受安慰剂的患者中,允许随后交叉使用贝克洛梅他,并进行六个月的观察期.
主要成果:
- 在12周内,贝克洛梅他喷雾剂使12名16名患者中的12名患者能够停止服用口服皮质类固醇,而与14名安慰剂接受者中只有1名进行了比较.
- 在停止服用口服皮质类固醇的患者中,上腺功能得到改善,并且在六个月内降低了类固醇毒性反应.
- 贝克洛梅他喷雾剂一般耐受良好,在一些患者中报告了无症状的疹和鼻炎.
结论:
- 贝克洛梅他二酸喷雾剂是慢性支气管喘的有效辅助疗法,显著减少了口服皮质类固醇的需要.
- 切换到贝克洛梅他喷雾剂可以改善上腺功能,并减少与长期口服类固醇使用相关的不良影响.
- 贝克洛米他喷雾剂在治疗慢性喘和缓解皮质类固醇引起的并发症方面具有良好的安全性.
相关概念视频
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...